Literature DB >> 18050197

Association of an IRF5 gene functional polymorphism with Sjögren's syndrome.

Corinne Miceli-Richard1, Emmanuelle Comets, Pascale Loiseau, Xavier Puechal, Eric Hachulla, Xavier Mariette.   

Abstract

OBJECTIVE: Interferon regulatory factor 5 (IRF-5) is a transcription factor involved in the regulation of the host defense. Previous studies have demonstrated a significant association of various IRF5 gene polymorphisms with systemic lupus erythematosus (SLE) in Caucasians. The purpose of this case-control study was to investigate whether IRF5 polymorphisms are involved in the genetic predisposition to primary Sjögren's syndrome (SS), an autoimmune disease closely related to SLE.
METHODS: We analyzed IRF5 rs2004640, rs2070197, rs10954213, and rs2280714 polymorphisms in a cohort of 212 primary SS patients and 162 healthy blood donors, all of whom were of Caucasian origin. The 4 polymorphisms examined were genotyped by competitive allele-specific polymerase chain reaction using fluorescence resonance energy transfer technology.
RESULTS: The IRF5 rs2004640 GT or TT genotype (T allele carriers) was identified in 87% of primary SS patients compared with 77% of controls (P = 0.01, odds ratio [OR] 1.93 [95% confidence interval (95% CI) 1.15-3.42]). The IRF5 rs2004640 T allele was found on 59% of chromosomes from primary SS patients compared with 52% of chromosomes from controls (P = 0.04, OR 1.36 [95% CI 1.01-1.83]). No significant association of primary SS with rs2070197, rs10954213, or rs2280714 was seen when they were analyzed independently. Nevertheless, haplotype reconstructions based on the 4 polymorphisms examined suggest that various allele combinations of rs2004640 and rs2070197 could define susceptibility or protective haplotypes.
CONCLUSION: This study is the first to demonstrate a significant association between primary SS and the IRF5 rs2004640 T allele. These results, which require further replication on larger populations, suggest that besides their association with identical major histocompatibility complex gene polymorphisms, primary SS and SLE share IRF gene polymorphisms as a common genetic susceptibility factor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18050197      PMCID: PMC3184606          DOI: 10.1002/art.23142

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  14 in total

Review 1.  The type I interferon system in systemic lupus erythematosus.

Authors:  Lars Rönnblom; Maija-Leena Eloranta; Gunnar V Alm
Journal:  Arthritis Rheum       Date:  2006-02

2.  TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus.

Authors:  M J Rood; M V van Krugten; E Zanelli; M W van der Linden; V Keijsers; G M Schreuder; W Verduyn; R G Westendorp; R R de Vries; F C Breedveld; C L Verweij; T W Huizinga
Journal:  Arthritis Rheum       Date:  2000-01

3.  A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus.

Authors:  Robert R Graham; Sergey V Kozyrev; Emily C Baechler; M V Prasad Linga Reddy; Robert M Plenge; Jason W Bauer; Ward A Ortmann; Thearith Koeuth; Ma Francisca González Escribano; Bernardo Pons-Estel; Michelle Petri; Mark Daly; Peter K Gregersen; Javier Martín; David Altshuler; Timothy W Behrens; Marta E Alarcón-Riquelme
Journal:  Nat Genet       Date:  2006-04-16       Impact factor: 38.330

4.  Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus.

Authors:  Snaevar Sigurdsson; Gunnel Nordmark; Harald H H Göring; Katarina Lindroos; Ann-Christin Wiman; Gunnar Sturfelt; Andreas Jönsen; Solbritt Rantapää-Dahlqvist; Bozena Möller; Juha Kere; Sari Koskenmies; Elisabeth Widén; Maija-Leena Eloranta; Heikki Julkunen; Helga Kristjansdottir; Kristjan Steinsson; Gunnar Alm; Lars Rönnblom; Ann-Christine Syvänen
Journal:  Am J Hum Genet       Date:  2005-01-18       Impact factor: 11.025

5.  Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.

Authors:  Kyriakos A Kirou; Christina Lee; Sandhya George; Kyriakos Louca; Margaret G E Peterson; Mary K Crow
Journal:  Arthritis Rheum       Date:  2005-05

6.  Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray.

Authors:  G-M Han; S-L Chen; N Shen; S Ye; C-D Bao; Y-Y Gu
Journal:  Genes Immun       Date:  2003-04       Impact factor: 2.676

7.  Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjögren's syndrome.

Authors:  Jacques-Eric Gottenberg; Marc Busson; Pascale Loiseau; Monique Dourche; Julien Cohen-Solal; Virginia Lepage; Dominique Charron; Corinne Miceli; Jean Sibilia; Xavier Mariette
Journal:  Arthritis Rheum       Date:  2004-02

8.  Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus.

Authors:  Robert R Graham; Chieko Kyogoku; Snaevar Sigurdsson; Irina A Vlasova; Leela R L Davies; Emily C Baechler; Robert M Plenge; Thearith Koeuth; Ward A Ortmann; Geoffrey Hom; Jason W Bauer; Clarence Gillett; Noel Burtt; Deborah S Cunninghame Graham; Robert Onofrio; Michelle Petri; Iva Gunnarsson; Elisabet Svenungsson; Lars Rönnblom; Gunnel Nordmark; Peter K Gregersen; Kathy Moser; Patrick M Gaffney; Lindsey A Criswell; Timothy J Vyse; Ann-Christine Syvänen; Paul R Bohjanen; Mark J Daly; Timothy W Behrens; David Altshuler
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-05       Impact factor: 11.205

9.  In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response.

Authors:  Jacques-Eric Gottenberg; Marc Busson; Pascale Loiseau; Julien Cohen-Solal; Virginia Lepage; Dominique Charron; Jean Sibilia; Xavier Mariette
Journal:  Arthritis Rheum       Date:  2003-08

10.  B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.

Authors:  Marc Ittah; Corinne Miceli-Richard; Jacques- Eric Gottenberg; Frédéric Lavie; Thierry Lazure; Nathalie Ba; Jérémie Sellam; Christine Lepajolec; Xavier Mariette
Journal:  Arthritis Res Ther       Date:  2006-02-28       Impact factor: 5.156

View more
  57 in total

1.  A possible genetic association with chronic fatigue in primary Sjögren's syndrome: a candidate gene study.

Authors:  Katrine Brække Norheim; Stephanie Le Hellard; Gunnel Nordmark; Erna Harboe; Lasse Gøransson; Johan G Brun; Marie Wahren-Herlenius; Roland Jonsson; Roald Omdal
Journal:  Rheumatol Int       Date:  2013-09-03       Impact factor: 2.631

2.  Genetics and genomics of Sjögren's syndrome: research provides clues to pathogenesis and novel therapies.

Authors:  Barbara M Segal; Abu N M Nazmul-Hossain; Ketan Patel; Pamela Hughes; Kathy L Moser; Nelson L Rhodus
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2011-04-16

Review 3.  Genome-wide association studies in Sjögren's syndrome: What do the genes tell us about disease pathogenesis?

Authors:  Peter D Burbelo; Kiran Ambatipudi; Ilias Alevizos
Journal:  Autoimmun Rev       Date:  2014-03-18       Impact factor: 9.754

Review 4.  Influence of microbial environment on autoimmunity.

Authors:  Alexander V Chervonsky
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

5.  IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses.

Authors:  Thomas Krausgruber; Katrina Blazek; Tim Smallie; Saba Alzabin; Helen Lockstone; Natasha Sahgal; Tracy Hussell; Marc Feldmann; Irina A Udalova
Journal:  Nat Immunol       Date:  2011-01-16       Impact factor: 25.606

6.  Current Aspects of Pathogenesis in Sjögren's Syndrome.

Authors:  Michael Voulgarelis; Athanasios G Tzioufas
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-12       Impact factor: 5.346

Review 7.  Update on Pathogenesis of Sjogren's Syndrome.

Authors:  Pulukool Sandhya; Biji Theyilamannil Kurien; Debashish Danda; Robert Hal Scofield
Journal:  Curr Rheumatol Rev       Date:  2017

8.  Association of interferon regulatory factor 5 (IRF5) gene polymorphisms with juvenile idiopathic arthritis.

Authors:  Samira Esmaeili Reykande; Arezou Rezaei; Maryam Sadr; Mahsima Shabani; Farnaz Najmi Varzaneh; Vahid Ziaee; Nima Rezaei
Journal:  Clin Rheumatol       Date:  2018-02-08       Impact factor: 2.980

Review 9.  Genes and Sjögren's syndrome.

Authors:  Beth L Cobb; Christopher J Lessard; John B Harley; Kathy L Moser
Journal:  Rheum Dis Clin North Am       Date:  2008-11       Impact factor: 2.670

Review 10.  Genetic associations in type I interferon related pathways with autoimmunity.

Authors:  Angélica M Delgado-Vega; Marta E Alarcón-Riquelme; Sergey V Kozyrev
Journal:  Arthritis Res Ther       Date:  2010-04-14       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.